Printer Friendly

SANDOZ GROUP REPORTS RESULTS FOR 1992

 BASLE, Switzerland, Jan. 21 /PRNewswire/ -- The Sandoz Group achieved consolidated sales of Sfr. 14.4 billion in 1992, an increase of more than Sfr. 1 billion or 8 percent compared with 1991, the company reported today. In local currencies, sales also grew by 8 percent.
 Sales developed as follows:
 SANDOZ GROUP
 Percent Increase
 1992 1991 Sfr. in local
 Sfr. billions currencies(A)
 Chemicals 2.45 2.36 4 5
 Pharma 6.87 6.27(B) 9 9
 Agro 1.23 1.16 6 4
 Seeds 1.02 0.95 7 3
 Nutrition 1.75 1.54 13 12
 Construction &
 environment 1.10 1.07 3 3
 Total 14.42 13.35(B) 8 8
 (A) Excluding high-inflation countries
 (B) Adjusted to reflect changes in billing practices in Japan.
 The recessionary trends which have affected broad sectors of the world economy have had an impact on the results of our divisional companies. Nevertheless, thanks to solid volume growth, all divisions increased sales. This is particularly true for pharmaceuticals and nutrition.
 Chemicals showed strong progress in the markets of North and South America and Asia. In Europe, where the economic situation has deteriorated, sales grew only slightly.
 Pharmaceuticals continued on its growth path, particularly in the field of prescription drugs. An above-average contribution was made by innovative new products such as SANDOSTATIN(R), LOMIR/DYNACIRC(R) and the recently launched LAMISIL(R). SANDIMMUN(R) continued its dynamic development and LEPONEX/CLOZARIL(R) advanced into the group of the top five products. In the OTC field, TAVIST(R) was successfully launched as a non-prescription drug in the United States, and CALCIUM SANDOZ(R) met with growing demand.
 The crop protection market was negatively affected by the reform of the common agricultural policy (CAP) in the European Community. Nevertheless, agro sales increased satisfactorily, due chiefly to the launch of new products.
 Higher sales of flower seeds, young plants and sugarbeet seeds led to a positive performance of the seeds division, notably in the highly competitive European markets.
 Nutrition achieved well above average growth thanks to excellent results with Wander's OVALTINE(R) and ISOSTAR(R) and to strong expansion in the adult dietics business.
 Construction and environment also reported higher sales in spite of the low construction volume worldwide. Advances were made in Europe, and the market leader position was reinforced in the U.S. and Japan.
 The operating performance of the divisional companies is expected to result in a substantial rise in group profits.
 -0- 1/21/93
 /CONTACT: James R. Simpson of Sandoz Corporation, 212-830-2444/


CO: The Sandoz Group ST: IN: MTC SU: ERN

SM-SH -- NY010 -- 7255 01/21/93 09:15 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 21, 1993
Words:440
Previous Article:ANDOVER TOGS, INC. NAMES BRUCE KATZ AS PRESIDENT OF ITS SASSON GIRL'S DIVISION
Next Article:SARA LEE CORPORATION REPORTS RECORD SALES AND EARNINGS FOR SECOND QUARTER 1993
Topics:


Related Articles
SANDOZ GROUP REPORTS RESULTS FOR 1991
SANDOZ ANNOUNCES JUNE SALES RESULTS
SANDOZ LTD. ANNOUNCES EARNINGS
SANDOZ GROUP REPORTS FIRST HALF RESULTS 1993
SANDOZ ANNOUNCES 1993 SALES
SANDOZ HIGHLIGHTS ITS 1993 RESULTS AND ANNOUNCES 1994 FIRST QUARTER SALES
SANDOZ SIGNS DEBT ISSUANCE PROGRAM
SANDOZ ANNOUNCES FIRST HALF SALES UP 17% IN LOCAL CURRENCIES, 6% IN SWISS FRANCS
SANDOZ ANNOUNCES 16% GROWTH IN LOCAL CURRENCIES FOR SALES TO SEPTEMBER 30
SANDOZ ANNOUNCES 14% GROWTH IN LOCAL CURRENCIES FOR SALES IN 1995

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters